# Nikita Volkov

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/nikita-volkov/

## Facts

| Field | Value |
| --- | --- |
| Citations | 971 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 11 |
| i10-index | 15 |
| Last Known Institution | State Budget Institution of Health St. Petersburg Clinical Research Center Specialized Types of Medical Care |
| OpenAlex ID | https://openalex.org/A5036477674 |
| ORCID iD | 0000-0002-6232-257X |
| Works | 99 |

## Researcher papers

- [Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study](https://scholariq.org/papers/adjuvant-abemaciclib-combined-with-endocrine-therapy-for-high-risk-early-breast/)
- [Tumor acidity: From hallmark of cancer to target of treatment](https://scholariq.org/papers/tumor-acidity-from-hallmark-of-cancer-to-target-of-treatment/)
- [Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer](https://scholariq.org/papers/final-results-of-right-choice-ribociclib-plus-endocrine-therapy-versus/)
- [Effect of silver oxide nanoparticles on tumor growth in vivo](https://scholariq.org/papers/effect-of-silver-oxide-nanoparticles-on-tumor-growth-in-vivo/)
- [Efficacy of immune checkpoint blockade in MUTYH-associated hereditary colorectal cancer](https://scholariq.org/papers/efficacy-of-immune-checkpoint-blockade-in-mutyh-associated-hereditary-colorectal/)
- [Resistance mechanisms to drug therapy in breast cancer and other solid tumors: An opinion](https://scholariq.org/papers/resistance-mechanisms-to-drug-therapy-in-breast-cancer-and-other-solid-tumors-an/)
- [Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer](https://scholariq.org/papers/evidence-for-predictive-role-of-brca1-and-btubiii-in-gastric-cancer/)
- [EGFR T790M Mutation in TKI-Naïve Clinical Samples: Frequency, Tissue Mosaicism, Predictive Value and Awareness on Artifacts](https://scholariq.org/papers/egfr-t790m-mutation-in-tki-naive-clinical-samples-frequency-tissue-mosaicism/)
- [Malignant neoplasm of the bronchi and lung: Russian clinical guidelines](https://scholariq.org/papers/malignant-neoplasm-of-the-bronchi-and-lung-russian-clinical-guidelines/)
- [Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants](https://scholariq.org/papers/variability-in-lung-cancer-response-to-alk-inhibitors-cannot-be-explained-by-the/)
- [Investigation of the mechanisms of resistance to osimertinib in patients with T790M-associated NSCLC](https://scholariq.org/papers/investigation-of-the-mechanisms-of-resistance-to-osimertinib-in-patients-with/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [State Budget Institution of Health St. Petersburg Clinical Research Center Specialized Types of Medical Care](https://scholariq.org/institutions/state-budget-institution-of-health-st-petersburg-clinical-research-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.